The global Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Vitreous tamponades are medical devices used during vitreoretinal surgery to seal retinal breaks and detachments of the retina. They help to flatten or reattach the retina following eye surgery. They come in both permanent and temporary types.
Market key trends: One of the key trends in the vitreous tamponades market is the growing preference for gas tamponades over silicone oil tamponades. Gas tamponades such as C3F8 and SF6 provide better visual outcomes for retinal detachment surgery as compared to silicone oil. They are absorbed gradually by the body and do not require secondary surgery for removal. In addition, gas tamponades have a lower risk of developing emulsification and inflammatory response. This factor is contributing to the rising adoption of gas tamponades and fueling market growth.
SWOT Analysis
Strength: The vitreous tamponades market has wide applications in retinal detachment repair surgeries. The tamponades provide ideal surface properties to seal retinal breaks and help in retinal reattachment.
Weakness: Limited reimbursement policies for vitreous tamponades and retinal surgeries hinders market growth. Few complications associated with use of tamponades such as cataract development and corneal decomposition.
Opportunity: Rising prevalence of eye conditions like diabetic retinopathy and retinal detachment drives the demand. Growing healthcare infrastructure and funding in emerging nations presents lucrative opportunities.
Threats: Strong presence of local manufacturers who provide tamponades at low costs pose pricing pressure on established players. Stringent regulatory approvals and compliance further delays new product launches.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth, exhibiting CAGR of 2.5% over the forecast period, due to increasing prevalence of retinal detachment across major regions. According to a report by WHO, around 17.7 million people suffer from retinal detachment each year globally.
Regional analysis – North America dominated the market and is expected to maintain its lead over the forecast period. This is attributed to growing geriatric population, stringent regulatory approvals for new retinal surgeries in the region. Asia Pacific exhibits growth prospects owing to increasing healthcare spending in China and India. Better access and adoption of vitreous tamponade procedures support growth in the region.
Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Leading players focus on new product launches, geographical expansion and partnerships with ophthalmology clinics to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
